Proteomic Landscape of Adeno-Associated Virus (AAV)-Producing HEK293 Cells

被引:23
|
作者
Strasser, Lisa [1 ]
Boi, Stefano [1 ]
Guapo, Felipe [1 ]
Donohue, Nicholas [1 ]
Barron, Niall [1 ,2 ]
Rainbow-Fletcher, Alana [3 ]
Bones, Jonathan [1 ,2 ]
机构
[1] NIBRT Natl Inst Bioproc Res & Training, Foster Ave, Dublin A94 X099, Ireland
[2] Univ Coll Dublin, Sch Chem & Bioproc Engn, Dublin D04 V1W8, Ireland
[3] Pharmaron, 12 Estuary Banks, Liverpool L24 8RB, Merseyside, England
关键词
proteomics; LC-MS/MS; SP3; label-free quantitation; HEK293; cells; adeno-associated virus (AAV); gene therapy; PLATFORM; DESIGN; VECTOR;
D O I
10.3390/ijms222111499
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Adeno-associated viral (AAV) vectors are widely used for gene therapy, providing treatment for diseases caused by absent or defective genes. Despite the success of gene therapy, AAV manufacturing is still challenging, with production yields being limited. With increased patient demand, improvements in host cell productivity through various engineering strategies will be necessary. Here, we study the host cell proteome of AAV5-producing HEK293 cells using reversed phase nano-liquid chromatography and tandem mass spectrometry (RPLC-MS/MS). Relative label-free quantitation (LFQ) was performed, allowing a comparison of transfected vs. untransfected cells. Gene ontology enrichment and pathway analysis revealed differential expression of proteins involved in fundamental cellular processes such as metabolism, proliferation, and cell death. Furthermore, changes in expression of proteins involved in endocytosis and lysosomal degradation were observed. Our data provides highly valuable insights into cellular mechanisms involved during recombinant AAV production by HEK293 cells, thus potentially enabling further improvements of gene therapy product manufacturing.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
    Michael F. Naso
    Brian Tomkowicz
    William L. Perry
    William R. Strohl
    BioDrugs, 2017, 31 : 317 - 334
  • [42] Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
    Naso, Michael F.
    Tomkowicz, Brian
    Perry, William L., III
    Strohl, William R.
    BIODRUGS, 2017, 31 (04) : 317 - 334
  • [43] Adeno-Associated Virus (AAV) Versus Immune Response
    Rabinowitz, Joseph
    Chan, Ying Kai
    Samulski, Richard Jude
    VIRUSES-BASEL, 2019, 11 (02):
  • [44] Adeno-associated virus (AAV) vectors in gene therapy
    Serra, C
    Zentilin, L
    Tafuro, S
    Falaschi, A
    Giacca, M
    MINERVA BIOTECNOLOGICA, 1997, 9 (03) : 155 - 165
  • [45] Application of aav (adeno-associated virus) to gene therapy
    Ozawa, Keiya
    JOURNAL OF GENE MEDICINE, 2008, 10 (04): : 436 - 436
  • [46] Towards Large-Scale Manufacturing of Adeno-Associated Virus by Transient Transfection of HEK293 Suspension Cells in a Stirred Tank Bioreactor Using Serum-Free Medium
    Chahal, Parminder
    Schulze, Erica Alessandra
    Bernier, Alice
    Lanthier, Stephane
    Coulombe, Nathalie
    Kamen, Amine
    Gilbert, Renald
    MOLECULAR THERAPY, 2016, 24 : S117 - S118
  • [47] STUDIES ON THE DEFECTIVENESS OF ADENO-ASSOCIATED VIRUS (AAV) .2. EFFECT OF GROWTH IN CV-1 CELLS ON THE REPLICATION OF ADENO-ASSOCIATED VIRUS
    YOUNG, JF
    MAYOR, HD
    VIROLOGY, 1979, 94 (02) : 342 - 351
  • [48] Clarification Studies on HEK293 Cell Lysate for AAV Production
    Gursky, Blake
    Belcher, Donald
    Davis, Corben
    Bodey, Elijah
    Yung, Bryant
    Davis, Adam
    Agbogbo, Frank
    Dismuke, David
    MOLECULAR THERAPY, 2022, 30 (04) : 190 - 190
  • [49] Transcriptomic and proteomic responses of human renal HEK293 cells to uranium toxicity
    Prat, O
    Berenguer, F
    Malard, V
    Tavan, E
    Sage, N
    Steinmetz, G
    Quemeneur, E
    PROTEOMICS, 2005, 5 (01) : 297 - 306
  • [50] Gene transfer into vascular cells using adeno-associated virus (AAV) vectors
    Maeda, Y
    Ikeda, U
    Ogasawara, Y
    Urabe, M
    Takizawa, T
    Saito, T
    Colosi, P
    Kurtzman, G
    Shimada, K
    Ozawa, K
    CARDIOVASCULAR RESEARCH, 1997, 35 (03) : 514 - 521